POMALIDOMIDE REIG JOFRE
As listed in the register: POMALIDOMIDE REIG JOFRE 4 mg, gélule
4 mg · gélule
- Prescription only
- Active substance
- Pomalidomide
- Made by
- LABORATORIO REIG JOFRE (ESPAGNE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States11 matching products
Bulgaria3 matching products
European UnionNo exact match for this strength and form
Canada6 matching products
Netherlands23 matching products
- Pomalidomide Synthon 4 mg 4 mg · capsule, hard2 makers
- Imnovid 4 mg 4 mg · capsule, hard
- Polidma 4 mg 4 mg · capsule, hard
- Pomalidomide Accord 4 mg harde capsules 4 mg · capsule, hard
- Pomalidomide Adalvo 4 mg 4 mg · capsule, hard
- Pomalidomide CF 4 mg 4 mg · capsule, hard
- Pomalidomide Devatis 4 mg 4 mg · capsule, hard
- Pomalidomide Eugia 4 mg 4 mg · capsule, hard
Details
| Made by | LABORATORIO REIG JOFRE (ESPAGNE) |
|---|---|
| Active substance | Pomalidomide |
| Strength | 4 mg |
| Form | gélule |
| Route | orale |
| Dispensing (as stated by the register) | médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE · prescription réservée aux spécialistes et services HEMATOLOGIE · prescription hospitalière · prescription nécessitant préalablement le recueil de l’accord de soins du patient · liste I · prescription réservée aux médecins compétents en maladie du sang · pour les femmes susceptibles de procréer : surveillance particulière pendant le traitement · prescription nécessitant la remise d'un carnet patient · prescription réservée aux médecins compétents en CANCEROLOGIE |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure décentralisée |
| Name in the register | POMALIDOMIDE REIG JOFRE 4 mg, gélule |
| Packs | 14 plaquettes prédécoupées unitairesPVC (ACLAR) polytrifluorochloroéthylène aluminium de 1 gélule · plaquette(s) PVC (ACLAR) polytrifluorochloroéthylène aluminium de 21 gélule(s) |
| CIS | 67099324 |
| CIP13 | 3400930310595 |
| CIP13 | 3400930310601 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.